Patients with Inflammatory Bowel Disease and the Higher Incidence of Clostridium Difficile Infection

This study aimed at analyzing the patients with inflammatory bowel disease and the higher incidence of clostridium difficile infection by emphasizing the theoretical review of studies discussing the  inflammatory bowel diseases (IBD), which include Crohn’s disease and ulcerative colitis. And by discussing the treatment of CDI in IBD patients, the diagnosis of CDI in IBD, and the risk factors for CDI in IBD. The study concluded that clinicians should be cautious about the chances of CDI in patients who have an exacerbation of IBD. At times the IBD flare cannot be differentiated from CDI requiring a high degree of clinical suspicion and vouching for early stool testing for toxin assay. When CDI in IBD are established primarily within two days of hospital admission it suggests that a good number of the infection was acquired before admission. CDI should, therefore, be suspected in differentiated diagnosis for intractable IBD patients, because many such patients need not present with a history of antibiotic exposure or hospital admission and may largely be receiving outpatient treatment